Literature DB >> 26486325

The role of TARBP2 in the development and progression of cancers.

Xin Yu1, Zheng Li2.   

Abstract

TARBP2 is a RNA-binding protein (RBP) involved in miRNA processing and maturation. TARBP2 plays significant roles in many biological and pathological conditions, including viral expression of HIV-1, microsatellite instability, cancer stem cell properties, and tumor progression. Overexpression of TARBP2 was observed in many cancers such as prostate cancer, cutaneous malignant melanoma, and adrenocortical carcinoma. In addition, TARBP2 was also found to be downregulated in some cancers including colorectal cancer, gastric cancer, Ewing sarcoma, and upper urinary tract urothelial carcinoma. Therefore, whether TARBP2 functions as the tumor suppressor or tumor promoter is conflicting. In the present review, we provide an overview of current knowledge concerning the role of TARBP2 in tumor development and progression.

Entities:  

Keywords:  Cancer; Oncogene; TARBP2; Tumor suppressor gene

Mesh:

Substances:

Year:  2015        PMID: 26486325     DOI: 10.1007/s13277-015-4273-6

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  21 in total

1.  Reassessing the TARBP2 mutation rate in hereditary nonpolyposis colorectal cancer.

Authors:  Pilar Garre; Pedro Pérez-Segura; Eduardo Díaz-Rubio; Trinidad Caldés; Miguel de la Hoya
Journal:  Nat Genet       Date:  2010-10       Impact factor: 38.330

2.  Trans-activation response (TAR) RNA-binding protein 2 is a novel modulator of transient receptor potential canonical 4 (TRPC4) protein.

Authors:  Jasmin Zimmermann; Lorenz Latta; Andreas Beck; Petra Leidinger; Claudia Fecher-Trost; Gabriel Schlenstedt; Eckart Meese; Ulrich Wissenbach; Veit Flockerzi
Journal:  J Biol Chem       Date:  2014-02-21       Impact factor: 5.157

3.  Metastasis-suppressor transcript destabilization through TARBP2 binding of mRNA hairpins.

Authors:  Hani Goodarzi; Steven Zhang; Colin G Buss; Lisa Fish; Saeed Tavazoie; Sohail F Tavazoie
Journal:  Nature       Date:  2014-07-09       Impact factor: 49.962

4.  A double-stranded RNA binding protein required for activation of repressed messages in mammalian germ cells.

Authors:  J Zhong; A H Peters; K Lee; R E Braun
Journal:  Nat Genet       Date:  1999-06       Impact factor: 38.330

Review 5.  The role of chemotherapy in the treatment of urothelial cell carcinoma of the upper urinary tract (UUT-UCC).

Authors:  François Audenet; David R Yates; Olivier Cussenot; Morgan Rouprêt
Journal:  Urol Oncol       Date:  2010-09-29       Impact factor: 3.498

Review 6.  Microsatellite instability: an update.

Authors:  Hiroyuki Yamamoto; Kohzoh Imai
Journal:  Arch Toxicol       Date:  2015-02-22       Impact factor: 5.153

7.  Somatic mutations and losses of expression of microRNA regulation-related genes AGO2 and TNRC6A in gastric and colorectal cancers.

Authors:  Min S Kim; Ji E Oh; Yoo R Kim; Sang W Park; Mi R Kang; Sung S Kim; Chang H Ahn; Nam J Yoo; Sug H Lee
Journal:  J Pathol       Date:  2010-06       Impact factor: 7.996

8.  A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function.

Authors:  Sonia A Melo; Santiago Ropero; Catia Moutinho; Lauri A Aaltonen; Hiroyuki Yamamoto; George A Calin; Simona Rossi; Agustin F Fernandez; Fatima Carneiro; Carla Oliveira; Bibiana Ferreira; Chang-Gong Liu; Alberto Villanueva; Gabriel Capella; Simo Schwartz; Ramin Shiekhattar; Manel Esteller
Journal:  Nat Genet       Date:  2009-02-15       Impact factor: 38.330

9.  Microsatellite instability and TARBP2 mutation study in upper urinary tract urothelial carcinoma.

Authors:  Shuting Bai; Amberly L Nunez; Shi Wei; Amy Ziober; Yuan Yao; John E Tomaszewski; Zhanyong Bing
Journal:  Am J Clin Pathol       Date:  2013-06       Impact factor: 2.493

10.  Low DICER1 expression is associated with poor clinical outcome in adrenocortical carcinoma.

Authors:  Gabriela Resende Vieira de Sousa; Tamaya C Ribeiro; Andre M Faria; Beatriz M P Mariani; Antonio M Lerario; Maria Claudia N Zerbini; Iberê C Soares; Alda Wakamatsu; Venancio A F Alves; Berenice B Mendonca; Maria Candida B V Fragoso; Ana Claudia Latronico; Madson Q Almeida
Journal:  Oncotarget       Date:  2015-09-08
View more
  4 in total

Review 1.  The role of microRNAs in the adrenocortical carcinomas.

Authors:  Xin Yu; Zheng Li
Journal:  Tumour Biol       Date:  2015-12-15

2.  Clinicopathological Significance of TARBP2, APP, and ZNF395 in Breast Cancer.

Authors:  Ryoko Oi; Hirotaka Koizumi; Ichiro Maeda; Akira Noguchi; Shinobu Tatsunami; Tsuguo Iwatani; Hisanori Kawamoto; Koichiro Tsugawa; Masayuki Takagi
Journal:  Breast Cancer (Auckl)       Date:  2016-12-08

3.  TARBP2-mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma.

Authors:  Hui-Huang Lai; Chih-Wei Li; Chih-Chen Hong; Hung-Yu Sun; Ching-Feng Chiu; Da-Liang Ou; Pai-Sheng Chen
Journal:  Mol Oncol       Date:  2019-02-22       Impact factor: 6.603

4.  Loss of TARBP2 Drives the Progression of Hepatocellular Carcinoma via miR-145-SERPINE1 Axis.

Authors:  Li-Man Li; Chang Chen; Ruo-Xi Ran; Jing-Tao Huang; Hui-Lung Sun; Chang Zeng; Zhou Zhang; Wei Zhang; Song-Mei Liu
Journal:  Front Oncol       Date:  2021-06-24       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.